Pharmaceuticals
Healthcare
Bottomline: Affirma-backed nutraceuticals maker Tirupati's financial see-saw continues
Nutraceuticals maker Tirupati Medicare recorded a hit in operational margin in FY23 after fluctuations last fiscal, even as the company’s ......
Healthcare
Bottomline: InvAscent-backed Symbiotec has struggled to break out; will FY25 be different?
Homegrown corticosteroid and hormones API-maker Symbiotec Lifesciences Pvt. Ltd’s revenue and profitability took a hit in FY23, even as the ......
Healthcare
Kotak's second special situations PE fund bankrolling big-ticket pharma acquisition
Kotak Alternate Asset Managers (previously Kotak Investment Advisors), the alternative investment arm of Kotak Group, which hit a first close of ......
Healthcare
Bain Capital tweaks exit plan from decade-old India portfolio company
American private equity firm Bain Capital, which has been particularly active in India this year having struck three new deals ......
Healthcare
InvAscent hits first close for new healthcare fund; strikes back-to-back PE deal
Homegrown healthcare-focussed private equity firm InvAscent has hit the first close for its latest fund, even as it struck a ......
Healthcare
Eris Lifesciences acquires two businesses from Biocon arm
Eris Lifesciences Ltd, a Mumbai-listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, has agreed to purchase ......
Healthcare
QHP Capital strikes an India-linked bolt-on deal; local PE firm gets an exit
QHP Capital, which started as a corporate venture arm of Quintiles (now IQVIA) and later spun out as NovaQuest that ......
Healthcare
Torrent Pharma in talks with multiple PE players for loan to partially fund Cipla bid
India's Torrent Pharmaceuticals is in preliminary talks with Apollo Global Management to secure a loan of up to $1 billion ......
Healthcare
Concord Biotech gains 27% on stock market debut as valuation tops $1 bn
Concord Biotech, a pharmaceutical ingredients maker, made a strong stock market debut on Friday with its shares listing at a ......
Healthcare
Biocon may list biosimilars business by 2025 first half: CEO
Indian biopharmaceutical company Biocon Ltd is planning to list its biosimilars business, a significant contributor to the company's total revenue, ......
Recommended for you
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News